Salford Royal Hospital
Salford, Manchester, M6 8HD, United Kingdom
NCT Number: NCT03253354
This study will explore the effects of 3 different neurostimulation methods on swallowing function in patients with dysphagia secondary to Parkinson's Disease
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Salford, Manchester, M6 8HD, United Kingdom
The aim of this study is to assess 3 novel neuromodulation approaches - namely, pharyngeal stimulation, high frequency (5Hz) repetitive transcranial magnetic stimulation and low frequency (1Hz) repetitive transcranial magnetic stimulation on swallowing function in patients with dysphagia after Parkinson's Disease. A total of 66 patients are planned to be recruited, randomised to one of the 3 technologies or a sham treatment. A single treatment will be given and the effects will be assessed with a barium exam called videofluoroscopy within the 1st hour after the treatment. In addition, some measures of brain function will be recorded, before and after the treatments using single pulse transcranial magnetic stimulation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Confirmed Parkinson's Disease with dysphagia
Exclusion criteria
Contraindications to magnetic stimulation, such as pacemakers, significant neuroleptic medications, pregnancy Other causes for dysphagia Unable to give informed written consent
Neurostimulation
Other names: pharyngeal stimulation
Time frame: 1 hour
Changes in penetration aspiration scale
Time frame: Immediately after, 30 and 60 minutes
Measures of brain function to single pulse TMS
University of Manchester
Other
Exploring Novel Neurostimulation Based Therapies for Swallowing Impairments in Parkinson's Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05319795
Basal Ganglia Diseases, Brain Diseases
Toronto, Ontario, Canada
View Trial DetailsNCT05700838
Basal Ganglia Diseases, Brain Diseases
New York, United States
View Trial DetailsNCT04889170
Basal Ganglia Diseases, Brain Diseases
Vienna, Austria
View Trial DetailsNCT03192358
Amyotrophic Lateral Sclerosis, Basal Ganglia Diseases
Gainesville, Florida, United States
View Trial Details